Our Institute

The NOVA Institute for Medical Systems Biology (NIMSB) is an international research institute established through a strategic partnership between NOVA University Lisbon (Portugal) and the Max Delbrück Center for Molecular Medicine (Berlin, Germany), with support from the European Union’s Horizon Europe Teaming for Excellence programme, the Portuguese Government, and the Municipality of Oeiras.

Established in 2023, NIMSB is creating a Centre of Excellence in Medical Systems Biology to drive progress in precision medicine. The institute integrates cutting-edge technologies—including single-cell and spatial multi-omics, artificial intelligence, and patient-derived models—to deepen our understanding of disease processes and support the development of early diagnostics and innovative therapeutic solutions. Our research groups are currently hosted at the Champalimaud Foundation Campus in Lisbon, which offers a vibrant international research setting, while the administrative offices are situated at the Flor da Murta Palace in Oeiras.

Our vision is to become a leading international center, advancing systems medicine and interdisciplinary collaboration, and contributing to improving patient outcomes and societal well-being. NIMSB plays an integral role in the expanding life sciences ecosystem in Oeiras, strengthening research, education, and innovation at the local and global levels.

OUR CURRENT LOCATIONS

 

      

Champalimaud Foundation

 

 

 Flor da Murta Palace

 

 

In the future, we will be in the

Oeiras Life Science Campus

NIMSB | NOVA Institute for Medical Systems Biology

Funding Agency European Commission/Horizon Europe/ Teaming for Excellence (HORIZON-WIDERA-2022-ACCESS-01-two-stage). Ref. 101060346

Project Coordinator Universidade NOVA de Lisboa; Project Beneficiaries Universidade NOVA de Lisboa and Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) in Berlin, Germany

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Research Executive Agency (REA). Neither the European Union nor the granting authority can be held responsible for them.